Trials / Conditions / Refractory Neoplasm
Refractory Neoplasm
3 registered clinical trials studyying Refractory Neoplasm.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | 9-ING-41 in Pediatric Patients With Refractory Malignancies. NCT04239092 | Actuate Therapeutics Inc. | Phase 1 |
| Active Not Recruiting | 9-ING-41 in Patients With Advanced Cancers NCT03678883 | Actuate Therapeutics Inc. | Phase 2 |
| Completed | Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers NCT03017833 | M.D. Anderson Cancer Center | Phase 1 |